计算溶液所需的质量、体积或浓度。
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
H197233-10mg |
10mg |
现货 ![]() |
| |
H197233-50mg |
50mg |
现货 ![]() |
| |
H197233-250mg |
250mg |
现货 ![]() |
| |
H197233-1g |
1g |
现货 ![]() |
| |
H197233-5g |
5g |
现货 ![]() |
|
别名 | 6-羟基多巴胺氢溴酸盐 | 2,4,5-三羟基苯乙胺氢溴酸盐 | 6 -羟基多巴胺 | 2-(2,4,5-三羟基苯基)乙胺氢溴酸盐 | 2,5-二羟基酪胺氢溴酸盐 |
---|---|
英文别名 | 2,5-Dihydroxytyramine hydrobromide | HY-B1081A | SY102034 | 6-OHDA hydrobromide6-Hydroxydopamine hydrobromide | 5-(2-aminoethyl)benzene-1,2,4-triol;hydrobromide | BCP25700 | NSC238469 | NSC-238469 | TWC1D4W0WB | EINECS 217-598-6 | 636-00-0 (HBr) | Q272904 |
规格或纯度 | ≥95% |
英文名称 | 6-Hydroxydopamine hydrobromide |
生化机理 | 破坏儿茶酚胺能终端的神经毒素。选择性儿茶酚胺能神经毒素。消耗大脑儿茶酚胺水平。destroys(xa0)digral dopaminergic neurons and their striatal terminal\xa0 in rat models of Parkinson's disease. |
应用 | Oxidopamine hydrobromide是一个有选择性的含有儿茶酚胺的神经毒素,通过神经元的传输机制吸收和积累降低大脑儿茶酚胺水平。 |
储存温度 | -20°C储存,充氩 |
运输条件 | 超低温冰袋运输 |
备注 | 有关更多信息,请参考SDS。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
产品介绍 |
Solutions should be freshly prepared and protected from exposure to light.Oxidopamine hydrobromide是一个有选择性的含有儿茶酚胺的神经毒素,通过神经元的传输机制吸收和积累降低大脑儿茶酚胺水平。 Solutions should be freshly prepared and protected from exposure to light. product description: 6-Hydroxydopamine is a selective catecholaminergic neurotoxin. Studies show that 6-Hydroxydopamine can be used to create an animal model of Parkinson's disease as it causes almost complete destruction of nigral dopaminergic neurons and their striatal terminals when injected into the substantia nigra of rats. 6-Hydroxydopamine induces apoptosis in PC12 cells. |
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
---|
EC号 | 211-247-0 |
---|---|
分子类型 | 小分子 |
IUPAC Name | 5-(2-aminoethyl)benzene-1,2,4-triol;hydrobromide |
INCHI | InChI=1S/C8H11NO3.BrH/c9-2-1-5-3-7(11)8(12)4-6(5)10;/h3-4,10-12H,1-2,9H2;1H |
InChi Key | MLACDGUOKDOLGC-UHFFFAOYSA-N |
Canonical SMILES | C1=C(C(=CC(=C1O)O)O)CCN.Br |
Isomeric SMILES | C1=C(C(=CC(=C1O)O)O)CCN.Br |
WGK Germany | 3 |
RTECS | DC4600000 |
PubChem CID | 176170 |
分子量 | 250.09 |
Beilstein号 | 3713280 |
溶解性 | 溶于DMSO,最高浓度 (mg/mL):50, 最高浓度(mM):199.93;溶于H2O,最高浓度 (mg/mL):50, 最高浓度(mM):199.93;溶于Ethanol,最高浓度 (mg/mL):50, 最高浓度(mM):199.93 |
---|---|
敏感性 | 对光和湿度敏感 |
熔点 | 216-220°C |
分子量 | 250.090 g/mol |
XLogP3 | |
氢键供体数Hydrogen Bond Donor Count | 5 |
氢键受体数Hydrogen Bond Acceptor Count | 4 |
可旋转键计数Rotatable Bond Count | 2 |
精确质量Exact Mass | 249 Da |
单同位素质量Monoisotopic Mass | 249 Da |
拓扑极表面积Topological Polar Surface Area | 86.700 Ų |
重原子数Heavy Atom Count | 13 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 142.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 0 |
共价键合单元计数Covalently-Bonded Unit Count | 2 |
象形图 | GHS07 |
---|---|
信号词 | Warning |
危险声明 |
H315: 引起皮肤刺激 H319: 引起严重眼睛刺激 H335: 可能引起呼吸道刺激 |
预防措施声明 |
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P302+P352: 如皮肤沾染:用水充分清洗。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P312: 打电话给毒物中心或医生。。。如果你觉得不舒服 P264: 处理后要彻底洗手。 P271: 仅在室外或通风良好的地方使用。 P304+P340: 如误吸入:将人转移到空气新鲜处,保持呼吸舒适体位。 P337+P313: 如仍觉眼刺激:求医/就诊。 P403+P233: 存放在通风良好的地方。保持容器密闭。 P332+P313: 如发生皮肤刺激:求医/就诊。 |
WGK Germany | 3 |
RTECS | DC4600000 |
个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
Purity(HPLC) | 95-100(%) |
---|---|
Purity(Titration by AgNO3) | 94.5-105.5(%) |
Appearance(H197233) | Beige to Tan to Brown Powder or Granules |
Proton NMR spectrum | Conforms to Structure |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
批号(Lot Number) | 证书类型 | 日期 | 货号 |
---|---|---|---|
![]() |
分析证书 | 22-09-02 | H197233 |
![]() |
分析证书 | 22-09-02 | H197233 |
![]() |
分析证书 | 22-09-02 | H197233 |
![]() |
分析证书 | 22-09-02 | H197233 |
![]() |
分析证书 | 22-09-02 | H197233 |
![]() |
分析证书 | 22-09-02 | H197233 |
![]() |
分析证书 | 21-12-20 | H197233 |
![]() |
分析证书 | 21-12-20 | H197233 |
![]() |
分析证书 | 21-12-20 | H197233 |
![]() |
分析证书 | 21-12-20 | H197233 |
![]() |
分析证书 | 21-12-20 | H197233 |
1. Xue-Yun Chen, Si-Ning Feng, Yin Bao, Yu-Xin Zhou, Fang Ba. (2023) Identification of Clec7a as the therapeutic target of rTMS in alleviating Parkinson's disease: targeting neuroinflammation. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1869 (166814). [PMID:37495085] [10.1016/j.bbadis.2023.166814] |
2. Yi-Kao Hu, Yi-Ming Liu, Xiao-Lin Bai, Chao Ma, Xun Liao. (2023) Screening of Monoamine Oxidase B Inhibitors from Fragaria nubicola by Ligand Fishing and Their Neuroprotective Effects. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 71 (1): (512–521). [PMID:36562659] [10.1021/acs.jafc.2c06630] |
3. Feifei Zhu, Han Chen, Jinying Han, Weiwei Zhou, Qi Tang, Qian Yu, Shangshang Ma, Xiaoyong Liu, Shuhao Huo, Keping Chen. (2022) Proteomic and Targeted Metabolomic Studies on a Silkworm Model of Parkinson’s Disease. JOURNAL OF PROTEOME RESEARCH, 21 (9): (2114–2123). [PMID:35959672] [10.1021/acs.jproteome.2c00149] |
1. Xue-Yun Chen, Si-Ning Feng, Yin Bao, Yu-Xin Zhou, Fang Ba. (2023) Identification of Clec7a as the therapeutic target of rTMS in alleviating Parkinson's disease: targeting neuroinflammation. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1869 (166814). [PMID:37495085] [10.1016/j.bbadis.2023.166814] |
2. Yi-Kao Hu, Yi-Ming Liu, Xiao-Lin Bai, Chao Ma, Xun Liao. (2023) Screening of Monoamine Oxidase B Inhibitors from Fragaria nubicola by Ligand Fishing and Their Neuroprotective Effects. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 71 (1): (512–521). [PMID:36562659] [10.1021/acs.jafc.2c06630] |
3. Feifei Zhu, Han Chen, Jinying Han, Weiwei Zhou, Qi Tang, Qian Yu, Shangshang Ma, Xiaoyong Liu, Shuhao Huo, Keping Chen. (2022) Proteomic and Targeted Metabolomic Studies on a Silkworm Model of Parkinson’s Disease. JOURNAL OF PROTEOME RESEARCH, 21 (9): (2114–2123). [PMID:35959672] [10.1021/acs.jproteome.2c00149] |